ClinicalTrials.gov · NCT07719088 · Not yet recruiting
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
Registry record
NCT07719088 on ClinicalTrials.gov. The registry's last update to this record was 13 October 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Charles Raison Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Psilocybin (Usona Institute) Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Change in Epigenetic/Biological Clock Profiling from Baseline to Week 4 and Week 16 | Change in Purpose in Life (PIL) from Baseline to Week 4 and Week 16 Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Not yet recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-10-13. Checked
Check history: NCT07719088 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Charles Raison
- Phase: Phase 1
- Status: Not yet recruiting
- Intervention: Psilocybin (Usona Institute)
- Primary outcome: Change in Epigenetic/Biological Clock Profiling from Baseline to Week 4 and Week 16 | Change in Purpose in Life (PIL) from Baseline to Week 4 and Week 16
- Countries: United States
- Start: December 2026
- Completion (estimated): December 2028
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.